非维生素K 拮抗剂口服抗凝药治疗房颤的新进展
杨洁， 王晓明 - 心脏杂志, 2019 - heartj.cn
… 抗凝药治疗房颤的新进展Research progress of non-vitamin K antagonist oral anticoagulant
… ,减少凝血因子Ⅱ,Ⅶ,Ⅸ, Ⅹ的合成和活性发挥作用,在瓣膜性及非瓣膜性房 颤(non-valvular atrial …
… ,减少凝血因子Ⅱ,Ⅶ,Ⅸ, Ⅹ的合成和活性发挥作用,在瓣膜性及非瓣膜性房 颤(non-valvular atrial …
非維他命K 拮抗劑口服抗凝血劑在亞洲心房纖維顫動病人的使用評估
林欣儀， 郭錦樺， 黃織芬， 湯頌君， 沈麗娟， 鄭建興 - 台灣中風醫誌, 2020 - airitilibrary.com
… the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur
Heart J 2018; 39: 13301393. … among Asian patients with non-valvular atrial fibrillation under …
Heart J 2018; 39: 13301393. … among Asian patients with non-valvular atrial fibrillation under …
非維他命K 拮抗劑口服抗凝血劑與抗癲癇藥物交互作用之探討
陳柏安， 林雅如， 傅維仁 - 台灣中風醫誌, 2020 - airitilibrary.com
… Association between use of non–vitamin k oral anti-… in non-valvular atrial fibrillation. JAMA
2017; 318: 1250-1259. 14. … Non-vitamin K antagonist oral anticoagulants (NOACs) are …
2017; 318: 1250-1259. 14. … Non-vitamin K antagonist oral anticoagulants (NOACs) are …
臺灣心房顫動患者抗凝血劑使用現況及預測因子
胡慕美 - 2015 - tdr.lib.ntu.edu.tw
… 目前新一代口服抗凝血劑 (Non-vitamin K antagonist oral anticoagulation; NOAC) 包括
dabigatran,rivaroxaban,apixaban已在臺灣上市,國際治療準則也建議這些藥品為warfarin之外的替代…
dabigatran,rivaroxaban,apixaban已在臺灣上市,國際治療準則也建議這些藥品為warfarin之外的替代…
[PDF][PDF] 非維生素K 拮抗劑口服抗凝藥在非瓣膜病心房顫動患者的消化道出血風險: 一項納入73314 例患者的隨機對照研究薈萃分析
鄭展宏， 柯于梵， 余漢濠 - 1948 年創刊1993 年復刊第18 卷第2 期(總第 …, 2018 - kwh.org.mo
… patients with non-valvular atrial fibrillation receiving non-vitamin k antagonist oral
anticoagulants… the risk of gastrointestinal bleeding in patients with Non-valvular atrial fibrillation …
anticoagulants… the risk of gastrointestinal bleeding in patients with Non-valvular atrial fibrillation …
非維生素K 拮抗劑口服抗凝血劑發生出血併發症對處方持續性的影響
許杏如， 楊昀鑫， 張晉瑋， 黃秋谷， 吳柏青 - 台灣醫學, 2019 - airitilibrary.com
… We conducted a chart review study to analyze the reasons of interrupting medications in
atrial fibrillation patients who took non-vitamin K antagonist oral anticoagulants (NOACs)-…
atrial fibrillation patients who took non-vitamin K antagonist oral anticoagulants (NOACs)-…
左心耳封堵术与口服抗凝药物应用于心房颤动患者有效性及安全性的meta 分析
任艳霞， 安智晶， 张得梅， 郭雪娅 - 上海交通大学学报(医学版), 2021 - xuebao.shsmu.edu.cn
… new oral anticoagulants" or "NOAC" or "novel oral anticoagulants" or "non-vitamin K antagonist
oral anticoagulants" … [warfarin and novel oral anticoagulants(NOAC)] in non-valvular atrial …
oral anticoagulants" … [warfarin and novel oral anticoagulants(NOAC)] in non-valvular atrial …
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… 非瓣膜性心房颤动(nonvalvular atrial fibrillation, NVAF)是AF中… direct oral anticoagulants
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
口服抗凝剂在非瓣膜性房颤伴慢性肾功能不全患者中的应用进展
李欣， 刘璐， 柳志红， 赵智慧， 罗勤， 赵青 - 协和医学杂志, 2022 - xhyxzz.pumch.cn
… better patient compliance. However, all the non-vitamin K antagonist oral anticoagulants are
… and thus their administration in patients with atrial fibrillation and chronic renal insufficiency …
… and thus their administration in patients with atrial fibrillation and chronic renal insufficiency …
[PDF][PDF] NOACs 用药教育对心房颤动患者抗凝认知水平的影响
李浩， 施芳红， 顾智淳， 沈珑， 张顺国， 刘晓琰 - 世界临床药物, 2019 - jwph.com.cn
… for non-vitamin K antagonist oral anticoagulant drugs (NOACs) in patients with atrial fibrillation,
… with and without concurrent medications and risk of major bleeding in nonvalvular atrial …
… with and without concurrent medications and risk of major bleeding in nonvalvular atrial …